NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 363 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $300,170 | -31.0% | 7,233 | 0.0% | 0.01% | -37.5% |
| Q1 2023 | $434,993 | -18.0% | 7,233 | 0.0% | 0.01% | -27.3% |
| Q4 2022 | $530,541 | -3.5% | 7,233 | 0.0% | 0.01% | -15.4% |
| Q3 2022 | $550,000 | +66.2% | 7,233 | +51.9% | 0.01% | +62.5% |
| Q2 2022 | $331,000 | -16.2% | 4,762 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $395,000 | +9.4% | 4,762 | -1.0% | 0.01% | 0.0% |
| Q4 2021 | $361,000 | -35.4% | 4,812 | 0.0% | 0.01% | -38.5% |
| Q3 2021 | $559,000 | -48.0% | 4,812 | -0.7% | 0.01% | -50.0% |
| Q2 2021 | $1,074,000 | +67.8% | 4,845 | +0.1% | 0.03% | +52.9% |
| Q1 2021 | $640,000 | -22.9% | 4,842 | +0.8% | 0.02% | -29.2% |
| Q4 2020 | $830,000 | – | 4,802 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |